Showing 1381-1390 of 1395 results for "".
- Mount Sinai Researchers Discover How to Restore Vision Using Retinal Stem Cellshttps://modernod.com/news/mount-sinai-researchers-discover-how-to-restore-vision-using-retinal-stem-cells/2479939/Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases
- Regeneron Faces Delay to FDA Approval of 12-Week Dosing Schedule for Eylea in Wet AMDhttps://modernod.com/news/regeneron-faces-delay-to-fda-approval-of-12-week-dosing-schedule-for-eylea-in-wet-amd/2479946/Regeneron announced that the FDA issued a complete response letter regarding a filing seeking approval of a 12-week dosing schedule for »Eylea (aflibercept) in patients wit
- Web Vision Technologies Receives Grants to Develop Vision Testing Devices for NASAhttps://modernod.com/news/web-vision-technologies-receives-grants-to-develop-vision-testing-devices-for-nasa/2479953/Web Vision Technologies was recently awarded two grants from Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine to develop vision-testing devices for the National Aeronautical Space Administration (NASA) to be used on the International Space Station (ISS). The
- International Sports Vision Association Announces Appointment of Gary Esterow as Executive Directorhttps://modernod.com/news/international-sports-vision-association-announces-appointment-of-gary-esterow-as-executive-director/2479964/The International Sports Vision Association (ISVA), an organization of optometrists, athletic trainers, therapists, physicians and sports teams dedicated to evaluating, training, and improving vision performance in athletes, announced the appointment of Gary Esterow as Executive Director.
- Guardion Health Sciences Receives Methods Patents to Standardize Vision Testinghttps://modernod.com/news/guardion-health-sciences-receives-methods-patents-to-standardize-vision-testing/2479965/On July 10 and July 17, 2018, Guardion Health Sciences was issued two patents by the United States Patent and Trademark Office, both entitled “Method and Apparatus for Visual Acuity Testing.” The first pat
- Prevent Blindness to Hold “Eyes on Capitol Hill” Advocacy Eventhttps://modernod.com/news/prevent-blindness-to-hold-thirteenth-annual-eyes-on-capitol-hill-advocacy-event/2480051/Prevent Blindness will be holding its 13th annual “Eyes on Capitol Hill” advocacy day on July 17, 2018, in Washington DC. Prevent Blindness and its affiliates will bring together citizens from across the country to meet with Congress and their staff to speak on vision issues and to request suppor
- ThromboGenics Plans Name Change to “Oxurion”https://modernod.com/news/thrombogenics-plans-name-change-to-oxurion/2480064/ThromboGenics announced its intention to change its name to “Oxurion” and the company’s stock ticker symbol from ‘THR” to “OXUR.” The company issued a convening notice seeking the approval of ThromboGenics’ shareholders for the name change at an Extraordinary Genera
- Staar Surgical Announces Resolution of FDA Warning Letterhttps://modernod.com/news/staar-surgical-announces-resolution-of-fda-warning-letter/2480080/STAAR Surgical announced that it received a close-out letter from the FDA on June 19, 2018 lifting a Warning Letter dated May 21, 2014. “The lifting of the Warning Letter is the result of a comprehensive remediation program that not only addressed the issues raised by the FDA in the 2014 W
- BioTime Announces $1.9 Million Grant for Continued Development of OpRegen for Dry-AMDhttps://modernod.com/news/biotime-announces-1-9-million-grant-for-continued-development-of-opregen-for-dry-amd/2480136/BioTime has been awarded a new grant for 2018 of up to 6.9 million Israeli New Shekels (approximately $1.9 million) from the Israel Innovation Authority (IIA). The grant provides funding for the continued development of OpRegen, and to date the IIA has provided annual grants totaling over $13 mil
- Telescope Implant for End-State Macular Degeneration Now on the Federal Supply Schedule and Available at VA Hospitalshttps://modernod.com/news/telescope-implant-for-end-state-macular-degeneration-now-on-the-federal-supply-schedule-and-available-at-va-hospitals/2480149/VisionCare announced that MellingMedical will distribute the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) to Department of Veteran’s Affairs hospitals, military hospitals, and other federal government healthcare facilities in the United States. MellingMedical provides medical su